Evidence map›Paper›PMID 28355569›Full record

ArticleCell reports2017

Severity of Demyelinating and Axonal Neuropathy Mouse Models Is Modified by Genes Affecting Structure and Function of Peripheral Nodes.

Kathryn H Morelli, Kevin L Seburn, David G Schroeder, Emily L Spaulding, Loiuse A Dionne, Gregory A Cox, Robert W Burgess

Open access · goldAbstract read
In one paragraph

Article in Cell reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
1.6field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 36 citations in OpenAlex.

  1. Junctions in Jeopardy: the neuromuscular junction is a selective pathological target in Charcot-Marie-Tooth disease.Mammalian genome : official journal of the International Mammalian Genome Society · 2026
    Review
  2. Genetic Deletion of Sarm1 in Mouse Models of Three Neurological Diseases.Journal of the peripheral nervous system : JPNS · 2025
    Article
  3. Article
  4. Lack of effect from genetic deletion of Hdac6 in a humanized mouse model of CMT2D.Journal of the peripheral nervous system : JPNS · 2024
    Article
  5. Article
  6. Testing SIPA1L2 as a modifier of CMT1A using mouse models.Journal of neuropathology and experimental neurology · 2024
    Article
  7. Article
  8. Article
  9. Article
  10. NMJ-related diseases beyond the congenital myasthenic syndromes.Frontiers in cell and developmental biology · 2023
    Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Impaired Mitochondrial Mobility in Charcot-Marie-Tooth Disease.Frontiers in cell and developmental biology · 2021
    Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Kathryn H MorelliThe Jackson Laboratory, Bar Harbor, ME 04609, USA; Graduate School of Biomedical Science and Engineering, University of Maine, Orono, ME 04469, USA.
Kevin L SeburnThe Jackson Laboratory, Bar Harbor, ME 04609, USA.
David G SchroederThe Jackson Laboratory, Bar Harbor, ME 04609, USA.
Emily L SpauldingThe Jackson Laboratory, Bar Harbor, ME 04609, USA; Graduate School of Biomedical Science and Engineering, University of Maine, Orono, ME 04469, USA.
Loiuse A DionneThe Jackson Laboratory, Bar Harbor, ME 04609, USA.
Gregory A CoxThe Jackson Laboratory, Bar Harbor, ME 04609, USA; Graduate School of Biomedical Science and Engineering, University of Maine, Orono, ME 04469, USA.
Robert W BurgessThe Jackson Laboratory, Bar Harbor, ME 04609, USA; Graduate School of Biomedical Science and Engineering, University of Maine, Orono, ME 04469, USA. Electronic address: robert.burgess@jax.org.
Jackson Laboratory · USUniversity of Maine · US

Funding

Shared Resource ManagementP30CA034196 · NCI · JACKSON LABORATORY · PI Mark D ADAMS · 1985 to 2026
$61.9M
The Jackson Laboratory Center for Precision Genetics: From New Models to Novel TherapeuticsU54OD020351 · OD · JACKSON LABORATORY · PI BURGESS, ROBERT W. · 2015 to 2019
$10.2M
Genetics of the Neuromuscular Junction: Mechanisms and Disease ModelsR01NS054154 · NINDS · JACKSON LABORATORY · PI BURGESS, ROBERT W. · 2006 to 2019
$6.0M
Genetic Control of Phospholipid Biosynthesis and Muscular DystrophyR01AR054170 · NIAMS · JACKSON LABORATORY · PI COX, GREGORY A. · 2007 to 2016
$4.4M
A Resource for Mouse Models of Peripheral NeuropathyR24NS098523 · NINDS · JACKSON LABORATORY · PI BOGDANIK, LAURENT P, BURGESS, ROBERT W. · 2016 to 2019
$1.2M
A Spontaneous Mouse Model of Motor Neuron DiseaseR21NS072675 · NINDS · JACKSON LABORATORY · PI BURGESS, ROBERT W., COX, GREGORY A. · 2010 to 2011
$489k
Transcriptional and Translational Profiling of Motor Neurons in Two Mouse Models of Charcot-Marie-Tooth Disease Type 2DF31NS100328 · NINDS · JACKSON LABORATORY · PI SPAULDING, EMILY LOUISA · 2017 to 2019
$87k
A Personalized Gene Therapy Approach for Charcot-Marie-Tooth DiseaseF31NS098540 · NINDS · JACKSON LABORATORY · PI MORELLI, KATHRYN H · 2017 to 2018
$49k
NCI NIH HHS P30 CA034196NIAMS NIH HHS R01 AR054170NIH HHS U54 OD020351NINDS NIH HHS F31 NS098540NINDS NIH HHS F31 NS100328NINDS NIH HHS R01 NS054154NINDS NIH HHS R21 NS072675NINDS NIH HHS R24 NS098523
6 · The paper itself

Abstract

Charcot-Marie-Tooth (CMT) disease is a clinically and genetically heterogeneous group of inherited polyneuropathies. Mutations in 80 genetic loci can cause forms of CMT, resulting in demyelination and axonal dysfunction. The clinical presentation, including sensory deficits, distal muscle weakness, and atrophy, can vary greatly in severity and progression. Here, we used mouse models of CMT to demonstrate genetic interactions that result in a more severe neuropathy phenotype. The cell adhesion molecule Nrcam and the Na

Indexed as

AnimalsAxonsCarrier ProteinsCell Adhesion MoleculesCharcot-Marie-Tooth DiseaseDemyelinating DiseasesDisease Models, AnimalHeterozygoteIntracellular Signaling Peptides and ProteinsMice, Inbred C57BLMutationNAV1.6 Voltage-Gated Sodium ChannelNeuromuscular JunctionPeripheral NervesCarrier ProteinsCell Adhesion MoleculesIntracellular Signaling Peptides and ProteinsNAV1.6 Voltage-Gated Sodium ChannelNrcam protein, mouseScn8a protein, mouseSh3tc2 protein, mouseaxonsCharcot-Marie-Tooth diseasedegenerationgenetic modifiershereditary sensorylength constantmotor neuropathy

Identifiers

PMID28355569
PMCPMC5415377
OpenAlexW2601449456

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.